Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.06, $0.02 better than the analyst estimate of $0.04. Revenue for the quarter came in at $88 million versus the consensus estimate of $85.31 million.

For earnings history and earnings-related data on Exelixis (EXEL) click here.